ScholarWorks@Korea University: Hong, Soon Jun

Detailed Information

Hong, Soon Jun (홍순준)

Department of Biomedical Sciences

Research Area

Tel 02-920-5445
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

amlodipine:7||hypertension:7||rosuvastatin:6||losartan:4||hypercholesterolemia:4||central blood pressure:3||telmisartan:3||drugeluting stent:3||percutaneous coronary intervention:3||Myocardial infarction:3||acute myocardial infarction:3||talin:3||myocardial infarction:3||Endothelial progenitor cell:2||drugeluting stents:2||Focal adhesion:2||combination therapy:2||hydrochlorothiazide:2||Angiotensin receptor blockers:2||Metabolic syndrome:2||singepill combination:2||Pitavastatin:2||combination:2||ezetimibe:2||Percutaneous coronary intervention:2||major adverse cardiac event:2||blood pressure:2||Ezetimibe:2||restenosis:2||Stem cell:2||Optical coherence tomography:2||Stents:2||chlorthalidone:2||Congenital coronary artery:2||Patent ductus arteriosus:2||Neointima:2||Rosuvastatin:2||Anomalous origin of left main coronary artery:2||coronary artery disease:2||Acute coronary syndrome:2||Hypercholesterolemia:2||Angiogenesis:2||Left ventricular systolic dysfunction:1||lipid bilayer:1||Percutaneous coronary interventions:1||Bifurcation:1||Major adverse cardiac event:1||registries:1||Sca1+cardiac stem cell:1||Atherosclerosis:1||Guidewire entrapment:1||stressinduced cardiomyopathy:1||Carvedilol:1||NTproBNP:1||Drugeluting stents:1||antiplatelet drug:1||peripheral arterial disease:1||treatment outcome:1||Takayasu arteritis:1||cardiac remodeling:1||Zotarolimus:1||TIMP2:1||Clinical sample pretreatment:1||Immunosensing performances:1||Cytokines:1||cytochrome P450 CYP2C19:1||P2Y12 receptor gene polymorphism:1||clinical outcome:1||recurrence:1||Chronic total occlusion:1||mechanotransduction:1||Instent restenosis:1||Cardiac sphere:1||troughpeak ratio:1||Newonset diabetes:1||Fimasartan:1||Diabetic patients:1||Catechin:1||Clopidogrel:1||mortality:1||Clinical efficacy:1||Thrombosis:1||platelet:1||ticagrelor:1||Endovascular procedures:1||optical coherence tomography:1||Adipose tissue:1||Adipose stem cell:1||Radial artery:1||ventricular dysfunction:1||Coronary artery fistula:1||hydroxymethylglutarylCoA reductase inhibitors:1||동맥관개존증:1||elderly:1||Remodeling:1||Transcatheter aortic valve replacement:1||Neointima formation:1||integrin activation:1||Hindlimb ischemia:1||Left main:1||Drugeluting stent:1||stents:1||Platelet inhibitors:1||Ticagrelor:1||sepsisinduced myocardial dysfunction:1||Slow release:1||triple combination:1||Extracellular matrix:1||indothiazinone:1||obesity:1||diabetic patients:1||focal adhesion:1||talin modulator:1||intramyocardial injection:1||Cholesterol:1||MCP1:1||metabolic syndrome:1||NGAL:1||Bronchial artery fistula:1||swine model:1||Circulating stem cells:1||Electrical cardioversion:1||atrial fibrillation:1||catheter ablation:1||Talin:1||mechanical force:1||Cardioprotection:1||smoothness index:1||Neointimal hyperplasia:1||Regulatory T cell:1||Coronary intervention:1||Immediate release:1||triglycerides:1||Regeneration:1||antiangiogenesis:1||ADSC sheet:1||Sphere:1||Fibroblast growth factor 2:1||Registries:1||Microfluidic system:1||Strain:1||Diabetes:1||Baseline drift correction:1||Pulmonary trunk:1||stent thrombosis:1||Atrial fibrillation:1||stable:1||Vascular injury:1||mechanosensor:1||Thymosin beta 4:1||Endothelial Differentiation:1||Vascularization:1||SDF1 alpha:1||nebivolol:1||aortic pressure:1||blood pressure monitoring:1||cardiovascular diseases:1||LDLC:1||intensive care unit:1||hypertriglyceridemia:1||Coronary disease:1||Bioresorbable vascular scaffold:1||Myocardium:1||cardiomyocyte survival:1||black raspberry:1||adipose stem cell:1||Continuous immunosensor:1||Endothelialcolony forming cell:1||Adult peripheral blood:1||adiposederived stem cells:1||retrograde coronary venous delivery:1||Angioplasty:1||Stenosis:1||coronary bifurcation lesion:1||secondgeneration drugeluting stent:1||Catheter ablation:1||angina:1||dyslipidemia:1||Vascular smooth muscle cell:1||lowdose:1||ambulatory:1||combination drug therapy:1||thiazides:1||.:1||coronary artery aneurysm:1||Aspirin:1||Heart failure with reduced ejection fraction:1||Human endothelial colonyforming cells:1||pleiotropic effect:1||engraftment:1||Everolimus:1||immortalization:1||secretome:1||endothelial progenitor cells:1||coronary artery stenosis:1||Coronary angiography:1||Vascular endothelial growth factor receptor:1||intravenous injection:1||Left main disease:1||MicroRNA:1||Ischemic hindlimb:1||Adipose:1||Pulmonary vein:1||Revascularization:1||curvature:1||integrin:1||transmembrane domain:1||Combination therapy:1||sepsis:1||nonHDLC:1||blood pressure control:1||Rhoassociated protein kinase:1||singlepill combination:1||acute coronary syndrome:1||balloon angioplasty:1||complication:1||KCH1521:1||adiposederived stem cell:1||Diabetes mellitus:1||in vitro angiogenesis:1||Left ventricle:1||Smooth muscle progenitor cell:1||Neovascularization:1||Aorta:1||microcirculatory resistance:1||diabetes:1||lowdensity lipoprotein cholesterol:1||Oxidative damage:1||echocardiography:1||Aortic valve stenosis:1||clopidogrel:1||membrane protein:1||Chronic coronary total occlusion:1||Adiposederived stem cells:1||Drug coated balloon:1||CXCR4:1||arterial stiffness:1||omega3 fatty acids:1||Gradient nanopattern plates:1||integrin IIb3:1||pulse wave velocity:1||prasugrel:1||stent implantation:1||Restenosis:1||cardiac stem cells:1||augmentation index:1||angiopoietin2:1||Poly2hydroxyethyl methaciylate:1||myocardial perfusion:1||Endothelial function:1||Pioglitazone:1||Antiserum aggregation:1||intracoronary delivery:1||Pluripotent embryonic stem cell markers:1||coronary disease:1||관상동맥:1||Trimetazidine:1||heart volume:1||

STATISTICS: Total View :6,889,975; Today View :25,687

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE